Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
 
  • Details

SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS

Journal
Leukemia
Journal Volume
29
Journal Issue
4
Pages
847-857
Date Issued
2015
Author(s)
Inoue D.
Kitaura J.
Matsui H.
HSIN-AN HOU  
WEN-CHIEN CHOU  
Nagamachi A.
Kawabata K.C.
Togami K.
Nagase R.
Horikawa S.
Saika M.
Micol J.-B.
Hayashi Y.
Harada Y.
Harada H.
Inaba T.
HWEI-FANG TIEN  
Abdel-Wahab O.
Kitamura T.
DOI
10.1038/leu.2014.301
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927699006&doi=10.1038%2fleu.2014.301&partnerID=40&md5=2582f632a45b2a24799c8b408c1d9bd5
https://scholars.lib.ntu.edu.tw/handle/123456789/537426
Abstract
Mutations in ASXL1 are frequent in patients with myelodysplastic syndrome (MDS) and are associated with adverse survival, yet the molecular pathogenesis of ASXL1 mutations (ASXL1-MT) is not fully understood. Recently, it has been found that deletion of Asxl1 or expression of C-terminal-truncating ASXL1-MTs inhibit myeloid differentiation and induce MDS-like disease in mice. Here, we find that SET-binding protein 1 (SETBP1) mutations (SETBP1-MT) are enriched among ASXL1-mutated MDS patients and associated with increased incidence of leukemic transformation, as well as shorter survival, suggesting that SETBP1-MT play a critical role in leukemic transformation of MDS. We identify that SETBP1-MT inhibit ubiquitination and subsequent degradation of SETBP1, resulting in increased expression. Expression of SETBP1-MT, in turn, inhibited protein phosphatase 2A activity, leading to Akt activation and enhanced expression of posterior Hoxa genes in ASXL1-mutant cells. Biologically, SETBP1-MT augmented ASXL1-MT-induced differentiation block, inhibited apoptosis and enhanced myeloid colony output. SETBP1-MT collaborated with ASXL1-MT in inducing acute myeloid leukemia in vivo. The combination of ASXL1-MT and SETBP1-MT activated a stem cell signature and repressed the tumor growth factor-β signaling pathway, in contrast to the ASXL1-MT-induced MDS model. These data reveal that SETBP1-MT are critical drivers of ASXL1-mutated MDS and identify several deregulated pathways as potential therapeutic targets in high-risk MDS. ? 2015 Macmillan Publishers Limited.
SDGs

[SDGs]SDG3

Other Subjects
binding protein; cancer growth factor; phosphoprotein phosphatase 2A; protein kinase B; SET binding protein 1; tumor growth factor beta; unclassified drug; ASXL1 protein, human; carrier protein; homeodomain protein; HoxA protein; nuclear protein; phosphoprotein phosphatase 2; protein kinase B; repressor protein; SETBP1 protein, human; transforming growth factor beta; acute granulocytic leukemia; adult; animal cell; animal experiment; animal model; apoptosis; Article; ASXL1 gene; controlled study; differentiation; enzyme activity; female; gene; gene expression; gene mutation; Hoxa gene; human; human cell; in vivo study; major clinical study; mouse; myelodysplastic syndrome; nonhuman; priority journal; protein degradation; protein expression; SETBP1 gene; stem cell; survival; ubiquitination; acute myeloblastic leukemia; animal; C57BL mouse; cell differentiation; cell transformation; gene expression regulation; genetics; HEK293 cell line; HL 60 cell line; metabolism; mortality; mutation; myelodysplastic syndrome; pathology; signal transduction; survival analysis; Adult; Animals; Apoptosis; Carrier Proteins; Cell Differentiation; Cell Transformation, Neoplastic; Gene Expression Regulation, Leukemic; HEK293 Cells; HL-60 Cells; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Mutation; Myelodysplastic Syndromes; Nuclear Proteins; Protein Phosphatase 2; Proteolysis; Proto-Oncogene Proteins c-akt; Repressor Proteins; Signal Transduction; Survival Analysis; Transforming Growth Factor beta; Ubiquitination
Publisher
Nature Publishing Group
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science